Why This Study Matters

Adults considering ADHD treatment often hear about many possible options—from medication to therapy to lifestyle changes. Understanding which treatments consistently improve symptoms can help patients make more informed decisions about care.

What the Study Looked At

This large network meta-analysis compared both medication and non-medication treatments for adult ADHD across many randomized trials. Researchers evaluated how different interventions affected core ADHD symptoms based on both patient self-reports and clinician ratings.

Key Findings

• Stimulant medications and atomoxetine consistently reduced core ADHD symptoms compared with placebo.
• Evidence for non-pharmacologic treatments was more variable across studies.
• Medications did not clearly improve long-term quality of life outcomes.
• The analysis highlighted significant gaps in long-term research.

My Take

In clinical practice, this finding aligns with what many psychiatrists observe: medications often produce the most reliable short-term improvement in core symptoms such as attention and impulsivity. At the same time, medication alone rarely solves every aspect of ADHD. Skills training, lifestyle adjustments, and therapy often play an important complementary role. One important point from this research is the limited long-term evidence—something we still need better studies to understand. ADHD is typically a chronic condition, so treatment plans should ideally look beyond short-term symptom relief.

Source
Ostinelli, Edoardo G et al. Comparative efficacy and acceptability of pharmacological, psychological, and neurostimulatory interventions for ADHD in adults: a systematic review and component network meta-analysis. The Lancet Psychiatry, Volume 12, Issue 1, 32 - 43. doi:10.1016/S2215-0366(24)00360-2.

If you're seeking evaluation or treatment for adult ADHD in the Bay Area, learn more about our approach here.